Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Xiushi Biopharma

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Cagrilintide

    02 1Linaclotide

    03 1Liraglutide

    04 1Retatrutide

    05 1Semaglutide

    06 1Tirzepatide

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Cagrilintide

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
      Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
      blank

      01

      Cagrilintide

      China
      Florida Innovation
      Not Confirmed
      arrow

      Cagrilintide

      China
      arrow
      Florida Innovation
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Xiushi Biopharma

      Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

      About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

      blank

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Linaclotide

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
        Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
        blank

        02

        Linaclotide

        China
        Florida Innovation
        Not Confirmed
        arrow

        Linaclotide

        China
        arrow
        Florida Innovation
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Xiushi Biopharma

        Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

        About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

        blank

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Liraglutide

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
          Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
          blank

          03

          Liraglutide

          China
          Florida Innovation
          Not Confirmed
          arrow

          Liraglutide

          China
          arrow
          Florida Innovation
          Not Confirmed
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Xiushi Biopharma

          Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

          About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

          blank

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
            Post an Enquiry Post an Enquiry
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Retatrutide

            Product
            Web Link

            Stock Recap
            #PipelineProspector

            Market
            Place

            Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
            Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
            blank

            04

            Retatrutide

            China
            Florida Innovation
            Not Confirmed
            arrow

            Retatrutide

            China
            arrow
            Florida Innovation
            Not Confirmed
            • fda
            • EDQM
            • WHO-GMP
            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
            Post an Enquiry Post an Enquiry
            Flag China
            Virtual Booth Virtual Booth
            Digital Content Digital Content

            Xiushi Biopharma

            Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

            About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

            blank

            Product
            Web Link

            Stock Recap
            #Pipeline Prospector

            Market
            Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
              Post an Enquiry Post an Enquiry
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Semaglutide

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
              Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
              blank

              05

              Semaglutide

              China
              Florida Innovation
              Not Confirmed
              arrow

              Semaglutide

              China
              arrow
              Florida Innovation
              Not Confirmed
              • fda
              • EDQM
              • WHO-GMP
              Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
              Post an Enquiry Post an Enquiry
              Flag China
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              Xiushi Biopharma

              Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

              About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

              blank

              Product
              Web Link

              Stock Recap
              #Pipeline Prospector

              Market
              Place

              Contact Supplier
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                Post an Enquiry Post an Enquiry
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Tirzepatide

                Product
                Web Link

                Stock Recap
                #PipelineProspector

                Market
                Place

                Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
                Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
                blank

                06

                Tirzepatide

                China
                Florida Innovation
                Not Confirmed
                arrow

                Tirzepatide

                China
                arrow
                Florida Innovation
                Not Confirmed
                • fda
                • EDQM
                • WHO-GMP
                Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
                Post an Enquiry Post an Enquiry
                Flag China
                Virtual Booth Virtual Booth
                Digital Content Digital Content

                Xiushi Biopharma

                Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

                About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

                blank

                Product
                Web Link

                Stock Recap
                #Pipeline Prospector

                Market
                Place

                Contact Xiushi Biopharma and get a quotation

                Xiushi Biopharma is a supplier offers 6 products (APIs, Excipients or Intermediates).

                Find a price of Semaglutide bulk with DMF offered by Xiushi Biopharma

                Find a price of Cagrilintide bulk offered by Xiushi Biopharma

                Find a price of Linaclotide bulk offered by Xiushi Biopharma

                Find a price of Liraglutide bulk offered by Xiushi Biopharma

                Find a price of Retatrutide bulk offered by Xiushi Biopharma

                Find a price of Tirzepatide bulk offered by Xiushi Biopharma